Consensus Simulations Plus, Inc.

Equities

SLP

US8292141053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
45.16 ^USD	+1.69%		-2.92%	+0.92%

Apr. 17	InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance	CI
Apr. 04	Sector Update: Health Care Stocks Slump Late Afternoon	MT

Evolution of the average Target Price on Simulations Plus, Inc.

Price target over the last 5 years

History of analyst recommendation changes

6.QO3oZhprr_pWi_oBtmzbXbarL6cV71LPbe4_F8Jqg8I.eICuLHgPzal76MpAziGfav7oScVgiGWGBIx3eqFH-7sv2IpSaw3_jgfZlQ~ca1e729b7744224a92d277ce36af2f39

Analyst Recommendations on Simulations Plus, Inc.

Simulations Plus Insider Sold Shares Worth $798,867, According to a Recent SEC Filing	Apr. 02	MT
Oppenheimer Adjusts Simulations Plus Price Target to $55 From $67, Maintains Outperform Rating	23-10-26	MT
Oppenheimer Raises Simulations' Plus Price Target to $67 From $65, Maintains Outperform Rating	23-06-21	MT
BTIG Initiates Simulations Plus at Buy With $55 Price Target	23-05-09	MT
Sidoti Cuts Price Target on Simulations Plus to $44 From $56, Keeps Neutral Rating	22-12-22	MT
Oppenheimer Adjusts Simulations Plus Price Target to $65 From $75, Maintains Outperform Rating	22-10-27	MT
Raymond James Adjusts Price Target on Simulations Plus to $70 From $54, Keeps Outperform Rating	22-08-29	MT
Raymond James Adjusts Simulations Plus Price Target to $70 From $54, Maintains Outperform Rating	22-08-26	MT
Craig Hallum Raises Simulations Plus' Price Target to $60 From $55, Buy Rating Kept	22-07-07	MT
Simulations Plus : Berenberg Discover AI Seminar presentation, April 26, 2022 - Form 8-K	22-04-26	PU
Berenberg Discover AI Seminar	22-04-25	FA
Simulations Plus to Present at the Berenberg Discover AI Seminar	22-04-19	BU
Craig-Hallum Upgrades Simulations Plus to Buy From Hold; Price Target is $53	21-10-26	MT
SIMULATIONS PLUS : Oppenheimer Adjusts Simulations Plus PT to $75 From $85 Following Fiscal Q3 Miss, Maintains Outperform Rating	21-07-13	MT
SIMULATIONS PLUS : Craig-Hallum Adjusts Price Target on Simulations Plus to $65 From $74, Maintains Hold Rating	21-07-13	MT
SIMULATIONS PLUS : Raymond James Adjusts Price Target on Simulations Plus to $54 From $95, Keeps Outperform Rating	21-07-13	MT
SIMULATIONS PLUS : Craig-Hallum Adjusts Simulations Plus' Price Target to $74 From $81, Maintains Hold Rating	21-04-13	MT
SIMULATIONS PLUS : Oppenheimer Adjusts Price Target for Simulations Plus to $85 From $79, Maintains Outperform Rating	21-01-12	MT
Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT™ Model for Oral Absorption of Peptides	21-01-05	CI
SIMULATIONS PLUS : Taglich Brothers Upgrades Simulations Plus to Buy From Speculative Buy; Lifts PT to $76 From $72	20-11-25	MT